Literature DB >> 11403735

Classification, epidemiology, and natural history of fibromyalgia.

K P White1, M Harth.   

Abstract

Fibromyalgia (FM), also known as fibromyalgia syndrome (FMS) and fibrositis, is a common form of nonarticular rheumatism that is associated with chronic generalized musculoskeletal pain, fatigue, and a long list of other complaints. Some have criticized the classification of FM as a distinct medical entity, but existing data suggest that individuals meeting the case definition for FM are clinically somewhat distinct from those with chronic widespread pain who do not meet the full FM definition. Clinic studies have found FM to be common in countries worldwide; these include studies in specialty and general clinics. The same is true of general population studies, which show the prevalence of FM to be between 0.5% and 5%. Knowledge about risk factors for FM is limited. Females are at greater risk, and risk appears to increase through middle age, then decline. Although some authors claim that an epidemic of FM has been fueled by an over-generous Western compensation system, there are no data that demonstrate an increasing incidence or prevalence of FM; moreover, existing data refute any association between FM prevalence and compensation. Claims that the FM label itself causes illness behavior and increased dependence on the medical system also are not supported by existing research. This article reviews the classification, epidemiology, and natural history of FM.

Entities:  

Mesh:

Year:  2001        PMID: 11403735     DOI: 10.1007/s11916-001-0021-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  89 in total

1.  Epidemiology of musculoskeletal disorders (complaints) and related disability in Canada.

Authors:  P Lee; A Helewa; H A Smythe; C Bombardier; C H Goldsmith
Journal:  J Rheumatol       Date:  1985-12       Impact factor: 4.666

Review 2.  Fibromyalgia 20 years later: what have we really accomplished?

Authors:  S Carette
Journal:  J Rheumatol       Date:  1995-04       Impact factor: 4.666

3.  Disabling fibromyalgia: appearance versus reality.

Authors:  R M Bennett
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

Review 4.  Fibromyalgia.

Authors:  F Wolfe
Journal:  Rheum Dis Clin North Am       Date:  1990-08       Impact factor: 2.670

5.  Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami.

Authors:  R Kwiatek; L Barnden; R Tedman; R Jarrett; J Chew; C Rowe; K Pile
Journal:  Arthritis Rheum       Date:  2000-12

Review 6.  Functional somatic syndromes.

Authors:  A J Barsky; J F Borus
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

Review 7.  Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence.

Authors:  Terence J Coderre; Joel Katz; Anthony L Vaccarino; Ronald Melzack
Journal:  Pain       Date:  1993-03       Impact factor: 6.961

8.  Population study of tender point counts and pain as evidence of fibromyalgia.

Authors:  P Croft; J Schollum; A Silman
Journal:  BMJ       Date:  1994-09-17

9.  The nature of U.S. rheumatology practice, 1977.

Authors:  W V Epstein; C J Henke
Journal:  Arthritis Rheum       Date:  1981-09

10.  Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease.

Authors:  P Chaiamnuay; J Darmawan; K D Muirden; P Assawatanabodee
Journal:  J Rheumatol       Date:  1998-07       Impact factor: 4.666

View more
  61 in total

Review 1.  Worldwide epidemiology of fibromyalgia.

Authors:  Luiz Paulo Queiroz
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 2.  Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.

Authors:  John McBeth; Matthew R Mulvey
Journal:  Nat Rev Rheumatol       Date:  2012-01-24       Impact factor: 20.543

3.  Increased absence due to sickness among employees with fibromyalgia.

Authors:  M Kivimäki; P Leino-Arjas; L Kaila-Kangas; M Virtanen; M Elovainio; S Puttonen; L Keltikangas-Järvinen; J Pentti; J Vahtera
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

Review 4.  Epidemiology of fibromyalgia.

Authors:  Lily Neumann; Dan Buskila
Journal:  Curr Pain Headache Rep       Date:  2003-10

5.  Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features.

Authors:  Marina de Tommaso; Maria Nolano; Florenzo Iannone; Eleonora Vecchio; Katia Ricci; Marta Lorenzo; Marianna Delussi; Francesco Girolamo; Vito Lavolpe; Vincenzo Provitera; Annamaria Stancanelli; Giovanni Lapadula; Paolo Livrea
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

6.  The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline.

Authors:  Luc Jasmin; Duc Tien; David Weinshenker; Richard D Palmiter; Paul G Green; Gabriella Janni; Peter T Ohara
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 7.  Fibromyalgia and nutrition, what do we know?

Authors:  Laura-Isabel Arranz; Miguel-Angel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2010-04-01       Impact factor: 2.631

Review 8.  Pregabalin: a review of its use in fibromyalgia.

Authors:  Katherine A Lyseng-Williamson; M Asif A Siddiqui
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Urinary albumin, protein excretion and circadian blood pressure in patients with fibromyalgia.

Authors:  Baris Afsar; Rukuye Burucu
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

10.  General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study.

Authors:  Karin Björkegren; Mari-Ann Wallander; Saga Johansson; Kurt Svärdsudd
Journal:  BMC Public Health       Date:  2009-10-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.